
Ainos: A med-tech firm offering low-dose interferon solutions and AI-powered preventive care.
Founded in San Diego, CA, Ainos is a medical technology company dedicated to revolutionizing healthcare through innovative solutions. Their core mission is to enhance patient outcomes by leveraging low-dose interferon drug solutions and AI-powered medical devices. Ainos envisions a future where preventive medicine is seamlessly integrated into everyday healthcare. Their product lineup includes the AI Nose, low-dose oral interferon, and synthetic RNA, targeting both the therapeutic and preventive medicine markets.
Ainos collaborates with notable agents like INABATA & CO., LTD. and TAIWAN ORIACT CO., LTD. The company has made significant strides in medical technology, particularly with their AI-powered devices that offer advanced diagnostic capabilities. Their low-dose interferon solutions have shown promise in various therapeutic applications, contributing to improved patient care. Through these innovations, Ainos has established itself as a key player in the med-tech industry, driving forward the integration of AI and biotechnology in healthcare.
Aibios
aibios.com

Ainnova Tech
ainnovatech.com

Avanos Medical
avanos.com

EchoNous
echonous.com

Intellisafe
intellisafe.ai

INVO Fertility
invobioscience.com

AIM ImmunoTech
aimimmuno.com

America Great Health
Infused Medical Technology

AyuVis Research
ayuvis.com
Airilabs

Amydis
amydis.com

Portal Instruments

iSono Health
isonohealth.com

Optain
optainhealth.com

Aerin Medical
aerinmedical.com

Medicreations
medicreations.com

AmplifiDx
amplifidx.com

Sonix Medical Devices

Idion
aionbiosystems.com
Ainos' most recent funding round was for $2.8M (USD) in April 2026.
As of Apr 1, 2026, Ainos has disclosed funding of $5.8M (USD).